KRAS and neoplasm: The anti-tumor effect of JQ1 was confirmed by Garcia et al. [154], where it was reported that the treatment of tumor-bearing mice with 0 mg/kg of JQ1 inhibited the growth of all the tumor-graft models (p < 0.05) containing the KRAS mutation.